Literature DB >> 30009636

Effect of a Virtual Reality-Based Exercise Program on Fatigue in Hospitalized Taiwanese End-Stage Renal Disease Patients Undergoing Hemodialysis.

Hsiao-Yu Chou1, Shu-Ching Chen1,2, Tzung-Hai Yen1,3, Hui-Mei Han1,2.   

Abstract

The purpose of this study was to evaluate the short-term effect of a virtual reality-based exercise program on fatigue in patients with end-stage renal disease (ESRD) who receive hemodialysis (HD). In this quasi-experimental study design, an experimental group (n = 32) received virtual reality training that promoted exercise, and a control group (n = 32) received routine care (advice on physical activities). Fatigue and physiologic parameters were assessed pretest (before intervention) as well as posttest (4 weeks after the onset of intervention). Our results showed that patients in the experimental group had significantly lower levels of overall fatigue, reduction in vigor and motivation, distress and loss of control in mood, and higher hemoglobin levels compared with the control group. ANCOVA revealed that there were no differences in overall fatigue and different domains of fatigue. Exercise only increased the blood urea nitrogen (BUN) and creatinine levels significantly in the intervention group.

Entities:  

Keywords:  end-stage renal disease; fatigue; hemodialysis; virtual reality-based program

Year:  2018        PMID: 30009636     DOI: 10.1177/1054773818788511

Source DB:  PubMed          Journal:  Clin Nurs Res        ISSN: 1054-7738            Impact factor:   2.075


  2 in total

1.  Mindfulness-based Virtual Reality Intervention in Hemodialysis Patients: A Pilot Study on End-user Perceptions and Safety.

Authors:  Rosalba Hernandez; Brett Burrows; Matthew H E M Browning; Killivalavan Solai; Drew Fast; Natalia O Litbarg; Kenneth R Wilund; Judith T Moskowitz
Journal:  Kidney360       Date:  2021-01-08

2.  Can hypnosis and virtual reality reduce anxiety, pain and fatigue among patients who undergo cardiac surgery: a randomised controlled trial.

Authors:  Floriane Rousseaux; Marie-Elisabeth Faymonville; Anne-Sophie Nyssen; Nadia Dardenne; Didier Ledoux; Paul B Massion; Audrey Vanhaudenhuyse
Journal:  Trials       Date:  2020-04-15       Impact factor: 2.279

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.